PT
Porosome Therapeutics, Inc.
SEC filingBiotechnology · Boston, MA
Amount raised$3.6Msold at filing
Total offeringNot stated
Investors in the raise7count reported to the SEC
FiledMar 24, 2026first sale Sep 8, 2023
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Guillermo MarmolExecutive Officer
Executive officers, directors and promoters as listed on the Form D.